Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
Authors:
- Steven A NarodSNSteven A Narod
- Ping SunPSPing Sun
- Parviz GhadirianPGParviz Ghadirian
- Henry LynchHLHenry Lynch
- Claudine IsaacsCIClaudine Isaacs
- Judy GarberJGJudy Garber
- Barbara WeberBWBarbara Weber
- Beth KarlanBKBeth Karlan
- David FishmanDFDavid Fishman
- Barry RosenBRBarry Rosen
- Nadine TungNTNadine Tung
- Susan L NeuhausenSNSusan L Neuhausen
- 1 May 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9267) , 1467-1470
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerThe American Journal of Human Genetics, 2001
- Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation CarriersThe American Journal of Human Genetics, 2001
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerThe American Journal of Human Genetics, 2000
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- Validity of self-reported hysterectomy and tubal sterilisationAustralian and New Zealand Journal of Public Health, 1997
- Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to CancerJAMA, 1997
- Cancer risk after a hospital discharge diagnosis of endometriosisAmerican Journal of Obstetrics and Gynecology, 1997
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Tubal Ligation, Hysterectomy, and Risk of Ovarian CancerJAMA, 1993